MOLECULAR IMAGING AND BIOLOGY
Scope & Guideline
Connecting Science and Imaging for Better Health Outcomes
Introduction
Aims and Scopes
- Molecular Imaging Techniques:
The journal emphasizes the development and application of various molecular imaging techniques, including PET, MRI, CT, and optical imaging, to visualize biological processes at the molecular and cellular levels. - Radiotracer Development:
A core focus is on the design, synthesis, and validation of new radiotracers and imaging agents, particularly those targeting specific biological pathways or disease markers. - Preclinical and Clinical Applications:
The journal publishes research that translates preclinical findings into clinical practice, exploring how molecular imaging can guide diagnosis, treatment planning, and monitoring of various diseases. - Theranostics:
A significant area of interest involves theranostics, where imaging and therapy are combined, allowing for personalized treatment strategies based on imaging findings. - Biomarkers and Disease Mechanisms:
The journal aims to highlight studies that identify and validate imaging biomarkers associated with disease mechanisms, progression, and treatment response. - Innovative Imaging Technologies:
It also covers advancements in imaging technologies, such as hybrid imaging modalities and novel imaging probes, which enhance the sensitivity and specificity of imaging assessments.
Trending and Emerging
- Machine Learning and AI in Imaging:
There is a significant increase in studies utilizing machine learning and artificial intelligence techniques to enhance image analysis, improve diagnostic accuracy, and predict treatment outcomes. - Targeted Molecular Imaging Probes:
Recent publications show a trend towards the development of highly specific targeted molecular imaging probes that can visualize particular cellular processes or disease states, enhancing the precision of diagnostic imaging. - Theranostic Applications:
The integration of imaging and therapeutic strategies (theranostics) is gaining momentum, with more studies exploring how imaging can guide therapy decisions and monitor treatment responses. - Immuno-PET and Immuno-Oncology:
There is a notable increase in research focusing on immuno-PET techniques and their applications in oncology, particularly for tracking immune responses and evaluating novel immunotherapeutic agents. - Advancements in Hybrid Imaging Technologies:
The rise of hybrid imaging technologies, combining modalities like PET/MRI and PET/CT, is becoming more prevalent, allowing for more comprehensive assessments of biological processes. - Real-Time Imaging Techniques:
Emerging studies are increasingly focusing on real-time imaging methods that enable dynamic monitoring of biological processes, particularly in the context of cancer treatment and cellular therapies.
Declining or Waning
- Traditional Imaging Modalities:
There seems to be a reduction in the publication of studies solely focused on traditional imaging methods without the integration of molecular or biological insights, indicating a shift towards more advanced and hybrid approaches. - Basic Imaging Methodologies:
Research centered around basic imaging techniques, such as standard CT or MRI without molecular imaging applications, is becoming less common, as the field evolves towards more innovative and specific applications. - Single-Modal Imaging Studies:
The prevalence of studies focusing exclusively on single-modal imaging techniques is declining, as the field increasingly favors multimodal approaches that provide more comprehensive insights into biological processes. - Conventional Radiomics:
While radiomics remains a significant area, there is a noticeable shift away from conventional radiomics methodologies towards more integrated and machine learning-based approaches that enhance predictive modeling. - Non-targeted Imaging Agents:
The use of non-targeted imaging agents in preclinical and clinical studies appears to be decreasing, with a stronger emphasis on targeted agents that provide higher specificity and relevance to particular diseases.
Similar Journals
PET Clinics
Advancing the Frontiers of PET Imaging.PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.
European Journal of Hybrid Imaging
Unlocking the Potential of Hybrid Imaging ResearchEuropean Journal of Hybrid Imaging, published by SpringerNature, stands as a pivotal platform for scholarly discourse in the rapidly evolving fields of hybrid imaging technologies and methodologies. Since its inception in 2017, this open access journal has significantly contributed to the interdisciplinary interface of biophysics, computer science, molecular medicine, and radiology. With its current standing in the Q2 and Q3 quartiles across various categories, it provides valuable insights and research outputs pertinent to both academic and clinical practitioners. The journal's rigorous peer-review process ensures the highest standards of scholarly integrity, while its open access format promotes global accessibility and encourages collaborative research efforts. Covering a diverse range of topics pertinent to hybrid imaging, the journal serves as an essential resource for researchers, professionals, and students alike, fostering innovation and knowledge exchange within the scientific community.
Radiology-Imaging Cancer
Illuminate the Future of Oncology with Cutting-Edge Radiology.Radiology-Imaging Cancer is a prestigious journal published by the Radiological Society of North America (RSNA), focusing on the critical intersection of radiology, oncology, and advanced imaging techniques. This journal stands out in its field with a commendable ranking in the Q2 category for Medicine (miscellaneous) and Oncology, and an impressive Q1 ranking in Radiology, Nuclear Medicine and Imaging, according to the 2023 quartiles. With an ISSN of 2638-616X, it serves as an essential platform for the dissemination of research that contributes to the understanding and improvement of cancer diagnosis and treatment. Its comprehensive scope encompasses a range of topics, from innovative imaging modalities to clinical applications in oncology, making it a valuable resource for researchers, clinicians, and students interested in the evolving field of cancer imaging. Despite being published in the United States, the journal aims for a global reach, catering to a wide audience dedicated to advancing medical science.
EJNMMI Research
Open Access to Tomorrow's Breakthroughs Today.EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.
CANCER IMAGING
Elevating Cancer Research with Open Access Imaging SolutionsCANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.
Theranostics
Transforming Therapeutics through Collaborative Research.Theranostics is a premier journal in the field of Medicine and Pharmacology, published by IVYSPRING INT PUBL. With its commitment to open access since 2011, it facilitates the widespread dissemination of innovative research, fostering collaboration and advancements in therapeutic diagnostics. The journal proudly holds a Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, Toxicology and Pharmaceutics, as of 2023, showcasing its esteemed position within the scientific community. Recognized globally, it ranks in the top 1%, with Scopus rankings placing it as 4th out of 398 in Medicine and 1st out of 43 in Pharmacology. Theranostics serves as a crucial platform for researchers, professionals, and students to explore cutting-edge developments as it converges multidisciplinary approaches to enhance patient care and treatment efficacy. With a focus on bridging experimental research and clinical applications, the journal is instrumental in shaping future therapies and diagnostic strategies.
Iranian Journal of Radiology
Pioneering Knowledge in the Evolving Field of RadiologyWelcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.
Indian Journal of Radiology and Imaging
Exploring the Depths of Diagnostic Imaging ExcellenceThe Indian Journal of Radiology and Imaging, published by THIEME MEDICAL PUBL INC, is a prominent open-access journal in the field of radiology, nuclear medicine, and imaging. Since its inception in 1984, the journal has provided a platform for researchers, professionals, and students to disseminate innovative research and findings in diagnostic imaging. With a growing impact factor and categorized in the Q3 quartile according to the 2023 rankings, it ranks among the notable journals in its field, although it currently stands at Rank #244 out of 333 within Scopus, reflecting its competitive position in radiology research. The journal, accessible to a global audience since 1999, aims to advance the knowledge and practice in imaging by inviting diverse contributions, including original research articles, reviews, and case reports. Its commitment to open-access publication fosters wider dissemination and collaborative discourse, crucial for the dynamic landscape of medical imaging.
Current Radiology Reports
Connecting researchers with transformative radiological discoveries.Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.
Hellenic Journal of Nuclear Medicine
Connecting Experts to Transform Nuclear Medicine PracticesThe Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.